ESR/CRP Ratio in SLE: Distinguishing Flare from Infection
A high ESR/CRP ratio (elevated ESR with relatively low CRP) suggests lupus flare, while a low ESR/CRP ratio (both elevated proportionally or CRP elevated more than ESR) indicates infection in febrile SLE patients.
The Diagnostic Utility
The ESR/CRP ratio serves as a practical tool when SLE patients present with fever and you need to differentiate between disease flare and infection—a critical clinical distinction that directly impacts morbidity and mortality through appropriate treatment selection.
Key Evidence
Each unit increase in the ESR:CRP ratio is associated with a 17% increase in the odds that fever is due to SLE flare rather than infection (OR 1.17,95% CI 1.04-1.31; p=0.009) 1. This finding was validated in a more recent 2024 study showing that the ESR/CRP ratio was negatively correlated with infection presence in SLE patients 2.
Clinical Interpretation Algorithm
When ESR/CRP Ratio is HIGH (ESR >> CRP):
- Suggests lupus flare
- ESR rises disproportionately due to immune complex formation, hypergammaglobulinemia, and chronic inflammation
- CRP remains relatively suppressed (lupus patients often have blunted CRP responses to disease activity due to interferon-alpha effects)
When ESR/CRP Ratio is LOW (both elevated or CRP > ESR):
- Suggests bacterial infection
- CRP rises acutely and dramatically with bacterial infection (6-8 hour response time)
- Both markers elevated proportionally or CRP predominates
Complementary Markers
While the ESR/CRP ratio provides valuable information, procalcitonin (PCT) is the best single predictor of infection in this context 2:
- PCT cut-off of 0.90 ng/mL provides 84.62% sensitivity and 85.71% specificity for infection
- PCT was the strongest independent predictor (OR 224.37) in multivariate analysis 2
The neutrophil-to-lymphocyte ratio (NLR) also correlates positively with infection presence and can serve as an additional supportive marker 2.
Critical Caveats
Important limitations to recognize:
- Neither ESR nor CRP individually distinguish flare from infection when modeled separately—only their ratio provides discriminatory value 1
- The ratio performs best in febrile presentations; its utility in afebrile disease activity is less established
- Concurrent infection and flare can coexist, particularly in immunosuppressed patients
- Other inflammatory conditions (concurrent arthritis, serositis) may confound interpretation
Clinical Context
While major SLE guidelines 3, 4, 5, 6 do not specifically address the ESR/CRP ratio for infection differentiation, they emphasize the importance of infection risk assessment and prevention strategies in SLE management. The ESR/CRP ratio fills a practical gap in the acute clinical setting when rapid differentiation is needed before culture results return.
In practice: Use the ESR/CRP ratio as part of a multi-marker approach, with PCT being the gold standard when available, to guide initial empiric decisions about antimicrobial therapy versus immunosuppression intensification in febrile SLE patients.